Iovance Biotherapeutics, Inc. (IOVA)
2.80
-0.05
(-1.75%)
USD |
NASDAQ |
Dec 29, 16:00
2.78
-0.02
(-0.71%)
After-Hours: 19:48
Iovance Biotherapeutics Shareholders Equity (Quarterly): 702.29M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | 5.054M |
| Lantheus Holdings, Inc. | 1.119B |
| iRhythm Technologies, Inc. | 121.89M |
| Day One Biopharmaceuticals, Inc. | 450.87M |
| Perspective Therapeutics, Inc. | 242.22M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 904.95M |
| Total Liabilities (Quarterly) | 202.66M |
| Debt to Equity Ratio | 0.0747 |
| Current Ratio | 3.411 |
| Net Debt Paydown Yield | 0.70% |